Insider Monkey41d agoneutral
Can AbbVie’s Backing Help ADARx Win Over Biotech IPO Investors at a $1.74 Billion Valuation?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey46d agoneutral
Nvidia Backed This AI Drug Startup. AbbVie Just Became a Partner Before Its IPOInvestor's Business Daily60d agoneutral
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?Barrons.com96d agoneutral
AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are OpenMT Newswires100d agoneutral
AbbVie Trims Full-Year Profit Outlook Due to Apogee AcquisitionThe Wall Street Journal100d agobullish
AbbVie Lowers Outlook to Account for Acquisition as Profit JumpsMotley Fool112d agoneutral
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?Insider Monkey130d agobullish
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition NewsMotley Fool131d agobullish
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?Insider Monkey138d agoneutral
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition